Huons Meditech Launches ‘Premium 9-Pin Needle 31G’ for Skin Booster Treatments
Huons Meditech Launches ‘Premium 9-Pin Needle 31G’ for Skin Booster Treatments
- Reducing Leakage and pain During Procedures -


▲ Huons Meditech's sterile injection needle 'Premium 9-Pin Needle 31G'
Huons Meditech, a medical device company under the Huons Group, is strengthening its competitiveness in the skin booster market by introducing a premium needle for enhanced treatment performance.
On the 20th, Huons Meditech (CEO Jinsuk Lee) announced the launch of its new sterile injection needle, the ‘Premium 9-Pin Needle 31G,’ designed to minimize drug leakage and pain during skin booster treatments.
The ‘Premium 9-Pin Needle 31G’ is a single-use, multi-sterile needle exclusively compatible with Huons Meditech’s signature product, the ‘Derma Shine,’ a precision drug delivery device. Derma Shine has achieved cumulative sales of over 20,000 units, leading the targeted drug injection market.
This new needle has been specifically developed for treatments involving skin boosters such as Juvelook, Rejuran, and Olidia. It is optimized for highly viscous ingredients like Poly-L-Lactic Acid (PLLA), Poly(D,L-lactic acid), and Polydeoxyribonucleotide (PDRN), ensuring minimal pain and leakage during injection.
Leveraging Huons Meditech’s extensive manufacturing expertise, the ‘Premium 9-Pin Needle 31G’ features a unique design that modifies the bevel length and needle structure. Internal and external tests have confirmed its effectiveness in reducing both leakage and pain. The needle also includes precision markings to control penetration depth accurately, and a protective cap for enhanced safety and convenience for medical professionals.
Jinsuk Lee, CEO of Huons Meditech, stated, “With the launch of the ‘Premium 9-Pin Needle 31G,’ we aim to minimize discomfort for patients and improve convenience for medical practitioners. Moving forward, we will continue to prioritize quality as our top value and strive to provide the best service to our customers.”
This new product is expected to further solidify Huons Meditech’s position in the skin booster market by offering a combination of precision, safety, and comfort.
Huons Group Chairman Yoon Sung-tae Attends in Inauguration of Endoscope Washer-Disinfector Production Line at India’s Vasu Group
Huons Meditech Showcases at ‘WHX Dubai 2026’
Huons Meditech Officially Launches ‘Dermashine Duo RF’, Combining Drug Delivery with Radiofrequency
Huons Meditech Participates in MEDICA 2025 in Germany
Huons Meditech Discusses Local Assembly Production Collaboration with India’s Vasu Group
Huons Meditech receives CE marking for Dermashine Pro
Huons Meditech offers a new paradigm for ESWT in urology
Huons Meditech drives global growth, participating in medical device symposiums in AU&US
Huons Meditech to showcase at Healthcare Trade Fair ‘Hospitalar 2025’ in Brazil
Huons Meditech receives Taiwan FDA approval for gynecological drug delivery system 'Jill'SOF'
Huons Group participates ‘Dubai Derma 2025’ for efforts to maximize sales
Huons Meditech officially launches Extracorporeal Shock Wave Therapy device ‘IMPO88 Plus’ for Erectile Dysfunction - Proven effect on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Treatment -